A Medical Device Daily
Radiant Research (Cincinnati) reported that it has completed discussions to establish a strategic partnership with contract research organization (CRO) Spectrum Clinical Research (Mumbai, India). This partnership will allow Radiant to provide CRO and site services across both North America and India.
"The demand for research capabilities outside of the U.S. is growing each year," said Julie McHugh, vice president of late phase clinical research at Radiant Research. "I was extremely impressed with Spectrum's quality programs and track record for recruitment. This partnership will allow our sponsors to place a global trial through Radiant and know that the same quality and expertise they have come to expect from our organization will be realized at our partner organization in India."
Radiant currently has a full service CRO, a patient recruitment division and 24 wholly-owned sites in the U.S. Radiant will now be able to manage and monitor studies conducted in India, as well as offer seven sites in India through the Spectrum network. Clients will be able to utilize the services of both organizations through one contract and one budget.
"This partnership is an excellent opportunity for our pharmaceutical sponsors to avail services of a local organization well versed in the local culture and capable of quick recruitment without loss of quality or deviation from U.S. standards and avoidance of multiple contracts," said Viral Shah, medical director of Spectrum Clinical Research.
Both Radiant and Spectrum share therapeutic expertise in asthma/allergy, endocrinology, cardiology, dermatology, gastroenterology, infectious disease, medical devices, men's and women's health, neurology, oncology, pulmonology, rheumatology and immunology/vaccine.
In other agreements/contracts news:
• Aspect Medical Systems (Norwood, Massachusetts) and First Manhattan (New York), which owns approximately 13.6% of the company's outstanding shares, reported that they have entered into an agreement in which Aspect will nominate the following three individuals at the 2009 annual meeting: Nassib Chamoun, Aspect's president/CEO, and two new independent director candidates including Jon Biro, currently executive vice president/CFO and accounting officer of Consolidated Graphics (Houston), and Melvin Keating, former president/CEO of Alliance Semiconductor (Santa Clara, California).
Aspect also agreed to appoint Vincent Scialli, managing director of First Manhattan, to the class of directors whose term will expire in 2011 immediately prior to the annual meeting.
• Premier Purchasing Partners (Charlotte, North Carolina) reported a new agreement for breast screening equipment - non-radiology has been awarded to NeoMatrix (Irvine, California). Effective April 1, the agreement is available to acute care and continuum of care members of the Premier healthcare alliance.